Prometheome
Prometheome is a Canadian research and development initiative founded in 2026, focused on longitudinal biological monitoring in cancer. We bring together scientific inquiry, technical innovation, and long-term thinking to explore new possibilities in cancer research. Further information about the initiative will be provided as the work progresses.
Team
Dr. Yahia Abdelali Lakehal
MD, FRCPC, MPHFounder & Scientific Lead
Dr. Lakehal is an internal medicine specialist and medical oncologist with a background in biochemistry and molecular medicine. His additional expertise in epidemiology and public health was developed through graduate study at Harvard University, complementing his clinical perspective with a population-level approach to cancer prevention and screening.
He is also involved in medical education and research in Montréal. As Prometheome’s founder, Dr. Lakehal leads its scientific direction and research strategy.
Norhan Mehrez
BSc, MAHead of Experimental Operations
Norhan holds a Bachelor of Science in Behavioural Neuroscience and a research-based master’s degree from Concordia University, with academic work spanning neuroscience, circadian biology, and adaptive immune function. Her professional background includes cancer clinical trials, biomedical research, biosafety, clinical environments, and operations management.
At Prometheome, Norhan leads experimental planning, technical evaluation, and the coordination of laboratory and research activities.